The Latest Breaking News from Vaccine

7 Vaccines Doctors Recommend for Adults Over 50

Turning 50 often comes with new priorities, and protecting your health moves higher on the list. While many people focus on exercise, diet, and preventive...

Saving Advice · Jun 15

Chikungunya Hits Mauritius as the CDC Now Has Four Simultaneous Active Outbreaks Listed — the Widest Multi-Country Chikungunya Warning Since 2014

CDC issued a new chikungunya travel notice for Mauritius on May 14, 2026 — now the fourth simultaneous active chikungunya outbreak notice alongside Suriname, French Guiana, and Mayotte. The FDA-approved Ixchiq vaccine is available but widely underutilized. Here is the full warning.

Medical Daily · Jun 15

Powassan Virus Can Cause Permanent Brain Damage After Just 15 Minutes of Tick Attachment as 2026's Record Tick Season Raises Risk Across the U.S.

Powassan virus is North America's most lethal tick-borne pathogen — killing 10% of neurological cases and leaving 50% of survivors with permanent deficits. It can transmit in as little as 15 minutes. With 2026 shaping up as one of the worst tick seasons ever, here is the complete warning for…

Medical Daily · Jun 15

Hepatitis A Outbreak in Canada Leaves 4 Dead, 142 Hospitalized; CDC Issues Travel Notice as Many Americans Traveling to Canada Remain Unvaccinated.

The CDC issued a hepatitis A travel notice for Manitoba, Canada on June 4, 2026. The outbreak has grown to 658 cases, 142 hospitalizations, and 4 deaths since April 2025. Winnipeg restaurant exposures have been identified. Here is what U.S. travelers need to know before visiting Canada.

Medical Daily · Jun 13

The First Lyme Disease Vaccine in 24 Years Just Passed Its Pivotal Phase 3 Trial with 74 Percent Efficacy — and It Is for Children Too

Pfizer and Valneva announced Phase 3 VALOR trial results for Lyme disease vaccine PF-07307405 on March 23, 2026: 73.2–74.8% efficacy in ages 5 and older. Regulatory submissions planned for 2026. No Lyme vaccine has been available in the U.S. since 2002.

Medical Daily · Jun 12

Mpox Clade I Has Spread Beyond Africa and Is Now Circulating Locally in Europe. The CDC Expects More U.S. Cases — and the Vaccine Gap Is Getting Harder to Ignore.

More than 20 clade I mpox cases have been confirmed in the U.S. as of June 2026. The CDC now expects additional cases as local clade Ib transmission has been detected in Europe among men who have sex with men with no travel history to Africa. JYNNEOS vaccine uptake lags…

Medical Daily · Jun 12

Whooping Cough Is Still Killing Americans in 2026, and California, Washington, Ohio, and Florida Are Leading a Surge That Is Far from Over

Whooping cough hit its highest U.S. case count in more than a decade in 2024 and 2025, killing infants and adults. In 2026, California leads the nation with nearly 700 cases. Falling vaccination rates, waning immunity, and public health cuts are driving the surge. Here is the full picture.

Medical Daily · Jun 12

Who is eligible for the MenB vaccine? New one-off programme to protect vulnerable to be rolled out

MenB is a serious bacterial infection caused by Neisseria meningitis group B

The Independent UK · Jun 12

UK to offer free Meningitis B vaccine to 1 million young people after deadly outbreaks

A major NHS programme will offer the meningitis B vaccine to around one million young people across the UK, including Year 13 students and those under 25 starting university. This initiative aims to protect vulnerable individuals entering environments where the disease spreads easily, following recent life-claiming outbreaks.

The Times of India · Jun 12

Meningitis B vaccine: Who is eligible – and when will it be offered?

IN FULL

The Independent UK · Jun 12